Histogen Inc. Common Stock
HSTO
HSTO was delisted on the 4th of October, 2023.
43 hedge funds and large institutions have $16.8M invested in Histogen Inc. Common Stock in 2015 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 14 increasing their positions, 7 reducing their positions, and 7 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 7
86% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 7
16% more funds holding
Funds holding: 37 → 43 (+6)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
46% less capital invested
Capital invested by funds: $30.9M → $16.8M (-$14.1M)
61% less call options, than puts
Call options by funds: $127K | Put options by funds: $329K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$1.15M |
| 2 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$377K |
| 3 |
D.E. Shaw & Co
New York
|
+$220K |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$154K |
| 5 |
AFM
Anson Funds Management
Dallas,
Texas
|
+$145K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jennison Associates
New York
|
-$2.93M |
| 2 |
Millennium Management
New York
|
-$1.8M |
| 3 |
IHM
Iguana Healthcare Management
New York
|
-$1.33M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$639K |
| 5 |
Citigroup
New York
|
-$549K |
HSTO Hedge Fund Activity: Q4 2015 in Review
43 of the 3,824 institutional investors tracked by Wall St. Rank reported a position in Histogen Inc. Common Stock (HSTO) for Q4 2015, worth a combined $16.8M — down 46% from $30.9M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new HSTO positions and 7 closed out — a net gain of 6 holders — while 14 added to existing stakes and 7 trimmed.
The largest buyer was Point72 Asset Management, opening a new position worth an estimated $1.15M. The largest seller was Jennison Associates, exiting entirely with an estimated $2.93M sold.
- 43 institutional investors held Histogen Inc. Common Stock (HSTO) as of Q4 2015, up from 37 in Q3 2015.
- Funds reported $16.8M of Histogen Inc. Common Stock stock for Q4 2015, down 46% quarter-over-quarter.
- 13 funds opened new Histogen Inc. Common Stock positions in Q4 2015 and 7 closed out, a net change of +6 holders.
- The largest Histogen Inc. Common Stock buyer in Q4 2015 was Point72 Asset Management, an estimated $1.15M added.
- The largest Histogen Inc. Common Stock seller in Q4 2015 was Jennison Associates, an estimated $2.93M sold.
Based on aggregated 13F filings for Q4 2015.